Project Number ADDF-4 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2020 View Full Project Details for Lead Optimization of Novel Site-Selective Blockers of Mitochondrial Complex III ROS as FTD Therapeutics Research Categorization Primary Disease / Condition Frontotemporal Dementia CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) j. Metabolism and Bioenergetics Researcher and Organization Principal Investigator Orr, Anna Principal Investigator First Name Anna Principal Investigator Last Name Orr Awardee Organization Weill Cornell Medical School Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement ADDF-Drug Development Request for Proposals FY Overall Cost $135,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States Program Official ADDF Grants Management
